About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Daily Archives: March 1, 2010
The Expanding Role of Twitter in Governance
Many of you will recall that in January, I published a White Paper called Twongress: The Power of Twitter in Congress – that provided analysis and insight into how members of Congress were utilizing Twitter to expand their own communications. … Continue reading
Posted in New and Social Media
2 Comments
Health Care Reform and Its Impact on FDA and Pharma
Last week, the excruciatingly long and unpredictable path of health care reform passed another milestone when President Obama held a summit at Blair House among leaders in Congress to try to forge out a bipartisan approach to a bill that would … Continue reading
Posted in FDA Policy, Legislation
Comments Off on Health Care Reform and Its Impact on FDA and Pharma